New York, May 22, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Gene Therapy Industry" - https://www.reportlinker.com/p05817594/?utm_source=GNW Poised to reach over US$125.3 Million by the year 2025, Lentivirus will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 30% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.3 Million to the regions size and clout in the next 5 to 6 years. Over US$117.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Lentivirus will reach a market size of US$6.5 Million by the close of the analysis period. As the worlds second largest economy and the new game changer in global markets, China exhibits the potential to grow at 39.2% over the next couple of years and add approximately US$797 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Read the full report: https://www.reportlinker.com/p05817594/?utm_source=GNW

GENE THERAPY MCP-1MARKET ANALYSIS, TRENDS, AND FORECASTS, MAY 2CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Global Competitor Market Shares Gene Therapy Competitor Market Share Scenario Worldwide (in %): 2019 & 2028 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: Gene Therapy Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 2: Gene Therapy Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 Table 3: Gene Therapy Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Lentivirus (Vector) World Market by Region/Country in US$ Thousand: 2020 to 2027 Table 5: Lentivirus (Vector) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 Table 6: Lentivirus (Vector) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: AAV (Vector) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 Table 8: AAV (Vector) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 Table 9: AAV (Vector) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: RetroVirus & Gamma RetroVirus (Vector) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 Table 11: RetroVirus & Gamma RetroVirus (Vector) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 Table 12: RetroVirus & Gamma RetroVirus (Vector) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 Table 13: Modified Herpes Simplex Virus (Vector) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2to 2027 Table 14: Modified Herpes Simplex Virus (Vector) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019 Table 15: Modified Herpes Simplex Virus (Vector) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 Table 16: Adenovirus (Vector) World Market by Region/Country in US$ Thousand: 2020 to 2027 Table 17: Adenovirus (Vector) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 Table 18: Adenovirus (Vector) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 Table 19: Other Applications (Vector) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027 Table 20: Other Applications (Vector) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2012 to 2019 Table 21: Other Applications (Vector) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Gene Therapy Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 22: United States Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2020 to 2027 Table 23: Gene Therapy Market in the United States by Vector: A Historic Review in US$ Thousand for 2012-2019 Table 24: United States Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 CANADA Table 25: Canadian Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020 to 2027 Table 26: Canadian Gene Therapy Historic Market Review by Vector in US$ Thousand: 2012-2019 Table 27: Gene Therapy Market in Canada: Percentage Share Breakdown of Sales by Vector for 2012, 2020, and 2027 JAPAN Table 28: Japanese Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2020-2027 Table 29: Gene Therapy Market in Japan: Historic Sales Analysis in US$ Thousand by Vector for the Period 2012-2019 Table 30: Japanese Gene Therapy Market Share Analysis by Vector: 2012 VS 2020 VS 2027 CHINA Table 31: Chinese Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2020-2027 Table 32: Gene Therapy Historic Market Analysis in China in US$ Thousand by Vector: 2012-2019 Table 33: Chinese Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2012, 2020, and 2027 EUROPE Market Facts & Figures European Gene Therapy Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 34: European Gene Therapy Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 Table 35: Gene Therapy Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 Table 36: European Gene Therapy Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 37: European Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020-2027 Table 38: Gene Therapy Market in Europe in US$ Thousand by Vector: A Historic Review for the Period 2012-2019 Table 39: European Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 FRANCE Table 40: Gene Therapy Market in France by Vector: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 41: French Gene Therapy Historic Market Scenario in US$ Thousand by Vector: 2012-2019 Table 42: French Gene Therapy Market Share Analysis by Vector: 2012 VS 2020 VS 2027 GERMANY Table 43: Gene Therapy Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2020-2027 Table 44: German Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2012-2019 Table 45: German Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 ITALY Table 46: Italian Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2020-2027 Table 47: Gene Therapy Historic Market Analysis in Italy in US$ Thousand by Vector: 2012-2019 Table 48: Italian Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2012, 2020, and 2027 UNITED KINGDOM Table 49: United Kingdom Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2020-2027 Table 50: Gene Therapy Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Vector for the Period 2012-2019 Table 51: United Kingdom Gene Therapy Market Share Analysis by Vector: 2012 VS 2020 VS 2027 SPAIN Table 52: Spanish Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020 to 2027 Table 53: Spanish Gene Therapy Historic Market Review by Vector in US$ Thousand: 2012-2019 Table 54: Gene Therapy Market in Spain: Percentage Share Breakdown of Sales by Vector for 2012, 2020, and 2027 RUSSIA Table 55: Russian Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2020 to 2027 Table 56: Gene Therapy Market in Russia by Vector: A Historic Review in US$ Thousand for 2012-2019 Table 57: Russian Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 REST OF EUROPE Table 58: Rest of Europe Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020-2027 Table 59: Gene Therapy Market in Rest of Europe in US$ Thousand by Vector: A Historic Review for the Period 2012-2019 Table 60: Rest of Europe Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 61: Asia-Pacific Gene Therapy Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 62: Gene Therapy Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019 Table 63: Asia-Pacific Gene Therapy Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 64: Gene Therapy Market in Asia-Pacific by Vector: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 65: Asia-Pacific Gene Therapy Historic Market Scenario in US$ Thousand by Vector: 2012-2019 Table 66: Asia-Pacific Gene Therapy Market Share Analysis by Vector: 2012 VS 2020 VS 2027 AUSTRALIA Table 67: Gene Therapy Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2020-2027 Table 68: Australian Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2012-2019 Table 69: Australian Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 INDIA Table 70: Indian Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020 to 2027 Table 71: Indian Gene Therapy Historic Market Review by Vector in US$ Thousand: 2012-2019 Table 72: Gene Therapy Market in India: Percentage Share Breakdown of Sales by Vector for 2012, 2020, and 2027 SOUTH KOREA Table 73: Gene Therapy Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2020-2027 Table 74: South Korean Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2012-2019 Table 75: Gene Therapy Market Share Distribution in South Korea by Vector: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 76: Rest of Asia-Pacific Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2020-2027 Table 77: Gene Therapy Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Vector for the Period 2012-2019 Table 78: Rest of Asia-Pacific Gene Therapy Market Share Analysis by Vector: 2012 VS 2020 VS 2027 LATIN AMERICA Table 79: Latin American Gene Therapy Market Trends by Region/Country in US$ Thousand: 2020-2027 Table 80: Gene Therapy Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019 Table 81: Latin American Gene Therapy Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 82: Latin American Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2020-2027 Table 83: Gene Therapy Historic Market Analysis in Latin America in US$ Thousand by Vector: 2012-2019 Table 84: Latin American Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2012, 2020, and 2027 ARGENTINA Table 85: Argentinean Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020-2027 Table 86: Gene Therapy Market in Argentina in US$ Thousand by Vector: A Historic Review for the Period 2012-2019 Table 87: Argentinean Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 BRAZIL Table 88: Gene Therapy Market in Brazil by Vector: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 89: Brazilian Gene Therapy Historic Market Scenario in US$ Thousand by Vector: 2012-2019 Table 90: Brazilian Gene Therapy Market Share Analysis by Vector: 2012 VS 2020 VS 2027 MEXICO Table 91: Gene Therapy Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2020-2027 Table 92: Mexican Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2012-2019 Table 93: Mexican Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 94: Rest of Latin America Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2020 to 2027 Table 95: Gene Therapy Market in Rest of Latin America by Vector: A Historic Review in US$ Thousand for 2012-2019 Table 96: Rest of Latin America Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 MIDDLE EAST Table 97: The Middle East Gene Therapy Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 98: Gene Therapy Market in the Middle East by Region/Country in US$ Thousand: 2012-2019 Table 99: The Middle East Gene Therapy Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 100: The Middle East Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020 to 2027 Table 101: The Middle East Gene Therapy Historic Market by Vector in US$ Thousand: 2012-2019 Table 102: Gene Therapy Market in the Middle East: Percentage Share Breakdown of Sales by Vector for 2012,2020, and 2027 IRAN Table 103: Iranian Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2020-2027 Table 104: Gene Therapy Market in Iran: Historic Sales Analysis in US$ Thousand by Vector for the Period 2012-2019 Table 105: Iranian Gene Therapy Market Share Analysis by Vector: 2012 VS 2020 VS 2027 ISRAEL Table 106: Israeli Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2020-2027 Table 107: Gene Therapy Market in Israel in US$ Thousand by Vector: A Historic Review for the Period 2012-2019 Table 108: Israeli Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 109: Saudi Arabian Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2020-2027 Table 110: Gene Therapy Historic Market Analysis in Saudi Arabia in US$ Thousand by Vector: 2012-2019 Table 111: Saudi Arabian Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2012, 2020, and 2027 UNITED ARAB EMIRATES Table 112: Gene Therapy Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2020-2027 Table 113: United Arab Emirates Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2012-2019 Table 114: Gene Therapy Market Share Distribution in United Arab Emirates by Vector: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 115: Gene Therapy Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2020-2027 Table 116: Rest of Middle East Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2012-2019 Table 117: Rest of Middle East Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 AFRICA Table 118: African Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2020 to 2027 Table 119: Gene Therapy Market in Africa by Vector: A Historic Review in US$ Thousand for 2012-2019 Table 120: African Gene Therapy Market Share Breakdown by Vector: 2012 VS 2020 VS 2027 IV. COMPETITION

Total Companies Profiled: 98 Read the full report: https://www.reportlinker.com/p05817594/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Original post:

Gene Therapy market worldwide is projected to grow by US$3.3 Billion - GlobeNewswire